Reuters logo
BRIEF-Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System
November 30, 2017 / 1:35 PM / in 12 days

BRIEF-Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System

Nov 30 (Reuters) - Cardinal Health Inc:

* CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below